Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis (Q39069010)

8 September 2017

Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis (English)

1 reference

Juan Carlos Hernandez-Boluda

8 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Joaquin Martinez-Lopez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Laura Fox

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Francisca Ferrer-Marín

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Francisco Cervantes

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Juan-Gonzalo Correa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Regina García-Delgado

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Alberto Alvarez-Larrán

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Valentín García-Gutiérrez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Manuel Pérez-Encinas

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

María-Isabel Mata-Vázquez

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

José-María Raya

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Natalia Estrada

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Silvia García

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Ana Kerguelen

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

María-Antonia Durán

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Manuel Albors

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

23 December 2016

1 reference

European Journal of Haematology

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

407-414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

Pathogenesis of myelofibrosis with myeloid metaplasia

8 June 2020

cites work

1 reference

Recent advances in understanding myelofibrosis and essential thrombocythemia

21 January 2018

1 reference

How I treat myelofibrosis.

21 January 2018

1 reference

Prognostication in primary myelofibrosis

21 January 2018

1 reference

Alleviating anemia and thrombocytopenia in myelofibrosis patients

21 January 2018

1 reference

Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients.

21 January 2018

1 reference

JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis

21 January 2018

1 reference

Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin

21 January 2018

1 reference

Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia: results in 20 patients and review of the literature.

21 January 2018

1 reference

Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2(V617F) and response to erythropoietin therapy

21 January 2018

1 reference

Recombinant human erythropoietin for the treatment of anaemia in patients with chronic idiopathic myelofibrosis.

21 January 2018

1 reference

Erythropoiesis stimulating agents have limited therapeutic activity in transfusion-dependent patients with primary myelofibrosis regardless of serum erythropoietin level.

21 January 2018

1 reference

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

21 January 2018

1 reference

Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report

21 January 2018

1 reference

How I treat patients with myelodysplastic syndromes

21 January 2018

1 reference

Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

21 January 2018

1 reference

Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.

21 January 2018

1 reference

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

21 January 2018

1 reference

Erythropoietin in cancer patients

21 January 2018

1 reference

Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EJH.12846

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28009442%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference